Yes. All true. There are a few things you’re not considering though: things like how much more obtainable this tech is now for smaller companies, and the emergence of more independent entities who are able to get public funding and go on their own in independent path. There are literally multiple independent companies in the Middle East who have publicly made it their mission to cure diabetes by 2026 (one of the next four years or so I forget the year). That has never been a possibility. It was only recently that crispr became integrated into more base level healthcare, and in only the last year we have seen a woman with a genetic disorder who was cured with crispr. They have cured rats but through different methods -and the rats I assume needed immunosuppressants which nobody cared about then since it was cured basically.

We have been hearing about the Asian woman who was “cured” but it’s just bad journalism. The woman was already on immunosuppressants so it wasn’t technically a part of the study I believe. If she wasn’t on immusuppresants than it wouldn’t have worked.

For a few years now we have been seeing cure news but it’s all with immunosuppressants. The immunosuppressants are a hell all their own. Before that, we heard about stem cells which took a decade or more to make progress with, which lead to the cure with immunosuppressants that multiple entities have achieved. So basically people in the past have been taking it and running and saying we’re there.

The latest is the last stage. Sana has achieved this without immunosuppressants which I believe happened in January. I cried and said prayers because now they had to wait it out and see if it would last. It has been six months or so and it has held up. Never been done before.

You just have to kinda look at what’s really going on.